Jerusalem, Israel

Raphael Mechoulam

USPTO Granted Patents = 44 

 

 

Average Co-Inventor Count = 3.9

ph-index = 16

Forward Citations = 685(Granted Patents)


Company Filing History:


Years Active: 1979-2025

Loading Chart...
Loading Chart...
Loading Chart...
44 patents (USPTO):

Title: The Pioneer of Cannabis Research - Raphael Mechoulam

Introduction: Raphael Mechoulam, a distinguished inventor hailing from Jerusalem, Israel, is renowned for his groundbreaking contributions to the field of cannabis research. His innovative work has significantly advanced our understanding of the medicinal properties of cannabis.

Latest Patents: As a prominent figure in the field of cannabis research, Mechoulam has been involved in numerous patents related to the extraction, synthesis, and potential medical applications of cannabinoids. His patents have paved the way for further developments in the use of cannabis-based treatments.

Career Highlights: Mechoulam's illustrious career spans several decades, during which he has conducted extensive research on the chemistry and pharmacology of cannabinoids. He is credited with the isolation and elucidation of the structure of THC, the primary psychoactive component of cannabis, a discovery that revolutionized the field.

Collaborations: Throughout his career, Mechoulam has collaborated with leading scientists, researchers, and medical professionals from around the world to further explore the potential therapeutic benefits of cannabinoids. His collaborative efforts have led to significant advancements in the field of cannabis research.

Conclusion: Raphael Mechoulam's pioneering work in cannabis research has had a profound impact on the scientific community and the medical field. His dedication to unraveling the mysteries of cannabinoids has laid the foundation for the development of innovative treatments and therapies. Mechoulam's contributions continue to inspire further research and exploration in the field of cannabis science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…